Contract 75D30122P15161
Gt Molecular, Inc. · Department Of Health And Human Services · August 26, 2022
Gt Molecular, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on August 26, 2022 for $297,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Fort Collins, CO. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 16, 2024.
Contract details
- PIID
- 75D30122P15161
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Support- Professional: Other
- Place of performance
- Fort Collins, CO
- First action
- August 26, 2022
- Latest action
- January 16, 2024
Description
NWSS MULTI-ASSAY PANEL DEVELOPMENT
Modification timeline
-
January 16, 2024Mod P00003$0
-
December 29, 2023Mod P00002$49.5K
-
August 9, 2023Mod P00001$62.5K
-
August 26, 2022Base award$185.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30122P15161?
Contract 75D30122P15161 is a federal contract awarded to Gt Molecular, Inc. by Department Of Health And Human Services on August 26, 2022 for $297,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75D30122P15161?
Gt Molecular, Inc. won contract 75D30122P15161 from Department Of Health And Human Services.
How much is contract 75D30122P15161 worth?
Contract 75D30122P15161 has obligated $297,000 to date.